利妥昔单抗能否改变血管内大B细胞淋巴瘤患者通常不佳的预后？ - Suppr

Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?

作者信息

Ferreri Andrés J M, Dognini Giuseppina P, Govi Silvia, Crocchiolo Roberto, Bouzani Maria, Bollinger Claudia R, D'Incan Michel, Delaporte Emmanuel, Hamadani Mehdi, Jardin Fabrice, Martusewicz-Boros Magdalena, Montanari Mauro, Szomor Arpad, Zucca Emanuele, Cavalli Franco, Ponzoni Maurilio

出版信息

J Clin Oncol. 2008 Nov 1;26(31):5134-6; author reply 5136-7. doi: 10.1200/JCO.2008.19.1841. Epub 2008 Oct 6.

DOI:10.1200/JCO.2008.19.1841

PMID:18838697

Abstract

摘要

相似文献

Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?利妥昔单抗能否改变血管内大B细胞淋巴瘤患者通常不佳的预后？

J Clin Oncol. 2008 Nov 1;26(31):5134-6; author reply 5136-7. doi: 10.1200/JCO.2008.19.1841. Epub 2008 Oct 6.

The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma.在基于蒽环类药物的化疗中加入利妥昔单抗可显著改善“西方”血管内大B细胞淋巴瘤患者的预后。

Br J Haematol. 2008 Oct;143(2):253-7. doi: 10.1111/j.1365-2141.2008.07338.x. Epub 2008 Aug 10.

Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma.含利妥昔单抗的缓解诱导疗法显著改善了初治成熟B细胞淋巴瘤的治疗效果。

Br J Haematol. 2008 Dec;143(5):672-80. doi: 10.1111/j.1365-2141.2008.07390.x. Epub 2008 Oct 20.

Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication.利妥昔单抗联合化疗治疗弥漫性大B细胞淋巴瘤。利妥昔单抗获该适应症批准前后的日常实践评估。

Hematol Oncol. 2008 Sep;26(3):139-47. doi: 10.1002/hon.850.

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.R-ESHAP方案作为复发或难治性弥漫性大B细胞淋巴瘤患者的挽救治疗：既往使用利妥昔单抗对疗效的影响。一项GEL/TAMO研究。

Haematologica. 2008 Dec;93(12):1829-36. doi: 10.3324/haematol.13440. Epub 2008 Oct 22.

Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤患者接受RCHOP化疗后出现的迟发性中性粒细胞减少症。

Am J Hematol. 2009 Jul;84(7):414-7. doi: 10.1002/ajh.21420.

Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan.日本IVL研究组报告的含利妥昔单抗化疗治疗血管内大B细胞淋巴瘤的回顾性分析。

J Clin Oncol. 2008 Jul 1;26(19):3189-95. doi: 10.1200/JCO.2007.15.4278. Epub 2008 May 27.

Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.首次复发时的绝对淋巴细胞计数可预测弥漫性大B细胞淋巴瘤患者的生存情况。

Am J Hematol. 2009 Feb;84(2):93-7. doi: 10.1002/ajh.21337.

Monoclonal antibodies in the management of newly diagnosed, aggressive B-cell lymphoma.

Curr Hematol Rep. 2003 Jan;2(1):23-9.

Rituximab and chemotherapy in diffuse large B-cell lymphoma.利妥昔单抗与化疗治疗弥漫性大B细胞淋巴瘤

Expert Rev Anticancer Ther. 2009 Jun;9(6):719-26. doi: 10.1586/era.09.30.

引用本文的文献

Evaluation of clinical biomarkers for differential diagnosis of intravascular lymphoma and Still's disease.用于血管内淋巴瘤和斯蒂尔病鉴别诊断的临床生物标志物评估

Sci Rep. 2025 Jul 4;15(1):23901. doi: 10.1038/s41598-025-09401-4.

A Rare Case of Adrenal Intravascular Large B-Cell Lymphoma Diagnosed via Percutaneous Needle Biopsy.经皮穿刺活检诊断肾上腺血管内大B细胞淋巴瘤1例罕见病例

World J Surg Oncol. 2025 May 23;23(1):200. doi: 10.1186/s12957-025-03855-6.

Clinical Spectrum, Diagnosis, and Treatment Outcome in Individuals With Intravascular Large B-cell Lymphoma Affecting the Nervous System: A Case Series.累及神经系统的血管内大B细胞淋巴瘤患者的临床谱、诊断及治疗结果：病例系列

Cureus. 2023 Apr 1;15(4):e37007. doi: 10.7759/cureus.37007. eCollection 2023 Apr.

A Rare Case of Intravascular Large B-cell Lymphoma Presenting With Bilateral Ophthalmoplegia, Along With a Literature Review.1例以双侧眼肌麻痹为表现的血管内大B细胞淋巴瘤罕见病例并文献复习

Cureus. 2022 Jun 14;14(6):e25920. doi: 10.7759/cureus.25920. eCollection 2022 Jun.

Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy.采用大剂量甲氨蝶呤和大剂量阿糖胞苷为主的中枢神经系统定向化学免疫疗法与蒽环类化学免疫疗法交替治疗成功治愈的伴中枢神经系统受累的血管内大B细胞淋巴瘤

Blood Lymphat Cancer. 2022 May 25;12:47-54. doi: 10.2147/BLCTT.S362736. eCollection 2022.

Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement.血管内大 B 细胞淋巴瘤：以皮肤累及的预后价值为重点的综述

Curr Oncol. 2022 Apr 19;29(5):2909-2919. doi: 10.3390/curroncol29050237.

Painful purpura from intravascular large B-cell lymphoma cutaneous variant.血管内大B细胞淋巴瘤皮肤变异型所致疼痛性紫癜

Proc (Bayl Univ Med Cent). 2021 Apr 13;34(5):613-615. doi: 10.1080/08998280.2021.1910781. eCollection 2021 Sep.

Current progress and future perspectives of research on intravascular large B-cell lymphoma.血管内大 B 细胞淋巴瘤研究的现状与展望。

Cancer Sci. 2021 Oct;112(10):3953-3961. doi: 10.1111/cas.15091. Epub 2021 Aug 9.

Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature.局限性肾血管内淋巴瘤：一例报告并文献复习

Case Rep Oncol Med. 2020 Oct 6;2020:7052536. doi: 10.1155/2020/7052536. eCollection 2020.

Primary lung intravascular large B-Cell lymphoma clinically mimicking sarcoidosis: A rare case report and review of literature.

Respir Med Case Rep. 2019 Dec 28;29:100989. doi: 10.1016/j.rmcr.2019.100989. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献